{"id":56327,"date":"2021-01-25T12:43:43","date_gmt":"2021-01-25T12:43:43","guid":{"rendered":"https:\/\/www.nettali.com\/?p=56327"},"modified":"2021-01-25T12:43:43","modified_gmt":"2021-01-25T12:43:43","slug":"coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces","status":"publish","type":"post","link":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/","title":{"rendered":"CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces"},"content":{"rendered":"<p>NETTALI.Com - Le groupe pharmaceutique am\u00e9ricain Merck a annonc\u00e9 lundi l'arr\u00eat du d\u00e9veloppement des deux vaccins contre le COVID-19 sur lesquels il travaillait, disant vouloir privil\u00e9gier la recherche sur des traitements de la maladie.<\/p>\n<p>Le groupe pr\u00e9cise dans un communiqu\u00e9 que l'arr\u00eat du d\u00e9veloppement des vaccins se traduira dans ses comptes du quatri\u00e8me trimestre 2020 par une charge exceptionnelle.<\/p>\n<p>Les deux vaccins, le V591, acquis avec le rachat de l'autrichien Themis Bioscience, et le V590, d\u00e9velopp\u00e9 avec l'organisation \u00e0 but non lucratif IAVI, ont g\u00e9n\u00e9r\u00e9 lors des premiers essais des r\u00e9ponses immunitaires inf\u00e9rieures \u00e0 celles observ\u00e9es chez des personnes ayant gu\u00e9ri du COVID-19 comme \u00e0 celles annonc\u00e9es pour d'autres vaccins, explique le laboratoire.<\/p>\n<p>Merck va donc concentrer ses efforts sur la recherche et la production de deux m\u00e9dicaments exp\u00e9rimentaux, le MK-7110 et le MK-4482, un antiviral administrable par voie orale qu'il appelle d\u00e9sormais molnupiravir.<\/p>\n<p>Merck dit esp\u00e9rer disposer au plus tard fin mars de premiers r\u00e9sultats d'essais cliniques sur le MK-7110.<\/p>\n<p>(Avec Reuters)<\/p>\n<div class='share-to-whatsapp-wrapper'><div class='share-on-whsp'>PARTAGER SUR : <\/div><a data-text='CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces' data-link='https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/' class='whatsapp-button whatsapp-share'>WhatsApp<\/a><div class='clear '><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>NETTALI.Com - Le groupe pharmaceutique am\u00e9ricain Merck a annonc\u00e9 lundi l'arr\u00eat du d\u00e9veloppement des deux vaccins contre le COVID-19 sur lesquels il travaillait, disant vouloir privil\u00e9gier la recherche sur des traitements de la maladie. Le groupe pr\u00e9cise dans un communiqu\u00e9 que l'arr\u00eat du d\u00e9veloppement des vaccins se traduira dans ses comptes du quatri\u00e8me trimestre 2020 [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":54410,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":""},"categories":[8],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.8 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces | Nettali.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces\" \/>\n<meta property=\"og:description\" content=\"NETTALI.Com - Le groupe pharmaceutique am\u00e9ricain Merck a annonc\u00e9 lundi l&#039;arr\u00eat du d\u00e9veloppement des deux vaccins contre le COVID-19 sur lesquels il travaillait, disant vouloir privil\u00e9gier la recherche sur des traitements de la maladie. Le groupe pr\u00e9cise dans un communiqu\u00e9 que l&#039;arr\u00eat du d\u00e9veloppement des vaccins se traduira dans ses comptes du quatri\u00e8me trimestre 2020 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/\" \/>\n<meta property=\"og:site_name\" content=\"Nettali.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nettalicom\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-25T12:43:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.nettali.com\/wp-content\/uploads\/2020\/12\/290420-vaccin-covid-oxford-m-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1244\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Thierno Diop\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.nettali.com\/#website\",\"url\":\"https:\/\/www.nettali.com\/\",\"name\":\"Nettali.com\",\"description\":\"Le rendez-vous critique du Net\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.nettali.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#primaryimage\",\"inLanguage\":\"fr-FR\",\"url\":\"https:\/\/www.nettali.com\/wp-content\/uploads\/2020\/12\/290420-vaccin-covid-oxford-m-1.jpg\",\"contentUrl\":\"https:\/\/www.nettali.com\/wp-content\/uploads\/2020\/12\/290420-vaccin-covid-oxford-m-1.jpg\",\"width\":1244,\"height\":720},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#webpage\",\"url\":\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/\",\"name\":\"CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces | Nettali.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.nettali.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#primaryimage\"},\"datePublished\":\"2021-01-25T12:43:43+00:00\",\"dateModified\":\"2021-01-25T12:43:43+00:00\",\"author\":{\"@id\":\"https:\/\/www.nettali.com\/#\/schema\/person\/8a06c6bd7b19304cf4bf985862900b5b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.nettali.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORONAVIRUS &#8211; Merck abandonne ses vaccins, pas assez efficaces\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.nettali.com\/#\/schema\/person\/8a06c6bd7b19304cf4bf985862900b5b\",\"name\":\"Thierno Diop\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.nettali.com\/#personlogo\",\"inLanguage\":\"fr-FR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c8ca58550c94fd2ac856d27391a6c866?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c8ca58550c94fd2ac856d27391a6c866?s=96&d=mm&r=g\",\"caption\":\"Thierno Diop\"},\"sameAs\":[\"https:\/\/nettali.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces | Nettali.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/","og_locale":"fr_FR","og_type":"article","og_title":"CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces","og_description":"NETTALI.Com - Le groupe pharmaceutique am\u00e9ricain Merck a annonc\u00e9 lundi l'arr\u00eat du d\u00e9veloppement des deux vaccins contre le COVID-19 sur lesquels il travaillait, disant vouloir privil\u00e9gier la recherche sur des traitements de la maladie. Le groupe pr\u00e9cise dans un communiqu\u00e9 que l'arr\u00eat du d\u00e9veloppement des vaccins se traduira dans ses comptes du quatri\u00e8me trimestre 2020 [&hellip;]","og_url":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/","og_site_name":"Nettali.com","article_publisher":"https:\/\/www.facebook.com\/nettalicom","article_published_time":"2021-01-25T12:43:43+00:00","og_image":[{"width":1244,"height":720,"url":"https:\/\/www.nettali.com\/wp-content\/uploads\/2020\/12\/290420-vaccin-covid-oxford-m-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Thierno Diop","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.nettali.com\/#website","url":"https:\/\/www.nettali.com\/","name":"Nettali.com","description":"Le rendez-vous critique du Net","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nettali.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"ImageObject","@id":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#primaryimage","inLanguage":"fr-FR","url":"https:\/\/www.nettali.com\/wp-content\/uploads\/2020\/12\/290420-vaccin-covid-oxford-m-1.jpg","contentUrl":"https:\/\/www.nettali.com\/wp-content\/uploads\/2020\/12\/290420-vaccin-covid-oxford-m-1.jpg","width":1244,"height":720},{"@type":"WebPage","@id":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#webpage","url":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/","name":"CORONAVIRUS - Merck abandonne ses vaccins, pas assez efficaces | Nettali.com","isPartOf":{"@id":"https:\/\/www.nettali.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#primaryimage"},"datePublished":"2021-01-25T12:43:43+00:00","dateModified":"2021-01-25T12:43:43+00:00","author":{"@id":"https:\/\/www.nettali.com\/#\/schema\/person\/8a06c6bd7b19304cf4bf985862900b5b"},"breadcrumb":{"@id":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.nettali.com\/2021\/01\/25\/coronavirus-merck-abandonne-ses-vaccins-pas-assez-efficaces\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.nettali.com\/"},{"@type":"ListItem","position":2,"name":"CORONAVIRUS &#8211; Merck abandonne ses vaccins, pas assez efficaces"}]},{"@type":"Person","@id":"https:\/\/www.nettali.com\/#\/schema\/person\/8a06c6bd7b19304cf4bf985862900b5b","name":"Thierno Diop","image":{"@type":"ImageObject","@id":"https:\/\/www.nettali.com\/#personlogo","inLanguage":"fr-FR","url":"https:\/\/secure.gravatar.com\/avatar\/c8ca58550c94fd2ac856d27391a6c866?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c8ca58550c94fd2ac856d27391a6c866?s=96&d=mm&r=g","caption":"Thierno Diop"},"sameAs":["https:\/\/nettali.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/posts\/56327"}],"collection":[{"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/comments?post=56327"}],"version-history":[{"count":1,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/posts\/56327\/revisions"}],"predecessor-version":[{"id":56328,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/posts\/56327\/revisions\/56328"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/media\/54410"}],"wp:attachment":[{"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/media?parent=56327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/categories?post=56327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nettali.com\/rest\/wp\/v2\/tags?post=56327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}